Attached files
file | filename |
---|---|
8-K - QUEST DIAGNOSTICS INC | c64094_8k.htm |
EX-99.1 - QUEST DIAGNOSTICS INC | c64094_ex99-1.htm |
Exhibit 99.2
QUEST DIAGNOSTICS INCREASES SHARE REPURCHASE
AUTHORITY
BY $750 MILLION
Increase brings current authorization to $1
billion
MADISON, N.J., January 25, 2011 Quest Diagnostics Incorporated (NYSE: DGX), the worlds leading provider of diagnostic testing, information and services, announced that its Board of Directors increased the companys share repurchase authorization by $750 million. This action increases the current share repurchase authorization to $1 billion.
During 2010, the company repurchased approximately 15 million shares of common stock for $750 million. The company had 171 million shares outstanding as of December 31, 2010.
About Quest
Diagnostics
Quest Diagnostics is the worlds leading provider of
diagnostic testing, information and services that patients and doctors need to
make better healthcare decisions. The company offers the broadest access to
diagnostic testing services through its network of laboratories and patient service
centers, and provides interpretive consultation through its extensive medical
and scientific staff. Quest Diagnostics is a pioneer in developing innovative
diagnostic tests and advanced healthcare information technology solutions that
help improve patient care.
# # #